Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
- Resource Type
- Source
- The Lancet Respiratory Medicine. 10:1169-1177
- Subject
Pulmonary and Respiratory Medicine - Language
- ISSN
- 2213-2600